ENG

Bird & Bird advised Biomemory on its €17 million fundraising round

Published

Dec 23 2024

Related

Practices

Sectors

Countries

International law firm Bird & Bird advised Biomemory, a French deeptech pioneer in DNA data storage, on its €17 million Series A funding round, with new investors Crédit Mutuel Innovation, Blast.club, Bpifrance, Sorbonne Venture and Adnexus, and its existing shareholders.

Founded in 2021, this innovative deeptech spin-off from CNRS/Sorbonne University’s first objective is to produce DNA printers that can transform binary information into AGTC information (the four types of DNA nucleotide).

Two years after a €5 million seed round, Biomemory plans to use this new funding to expand its team by recruiting promising talent in molecular biology and engineering to accelerate product development and commercialisation. 

The Bird & Bird team advising on the deal consisted of lead partner Félicien Bardsley and associate Céline Sol. 

News & Deals

More News & Deals

News

Bird & Bird advises on the sale of a controlling interest in international creative agency, Amplify, to Common Interest

Apr 08 2025

Read More

Deal

Bird & Bird advises FIECON on sale to Herspiegel

Apr 07 2025

Read More

News

Bird & Bird Advises Southern Alliance Mineral on Strategic Stake Acquisition in MCRE Resources

Apr 07 2025

Read More

Deal

Bird & Bird advises Fonds Stratégique des Transitions, on its participation in the €16 million financing round of EPSOR

Apr 04 2025

Read More

News

Bird & Bird secures important judgment for Destin Trading Inc in The High Court

Mar 28 2025

Read More

News

Bird & Bird secures important victory for wealth manager XY against ex-Ferrari Chairman

Mar 28 2025

Read More
More News & Deals

Related capabilities

Corporate Venture Capital Technology & Communications Life Sciences and Healthcare